Abbott Gets FDA Clearance For Alinity M STI Assay Test - Quick Facts
(RTTNews) - Abbott (ABT) has received FDA clearance for its Alinity m STI Assay test, which simultaneously detects and differentiates four common sexually transmitted infections. The Alinity m STI test for Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, and Mycoplasma genitalium. It requires one swab sample or a urine sample collected in a healthcare setting. The test runs on Abbott's Alinity m system.
Alinity m uses polymerase chain reaction technology, with high sensitivity in detecting infectious diseases. The company said the availability of the Alinity m system and tests varies by geography.
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.